CA
NZ
UK
AU
IND
US
●Name change and split:The board approved renaming the company Flyte Aviation, Inc. and executing a 1-for-10 reverse stock split, both effective 12:01 a.m. Eastern October 5, 2026.
●Verdict:A federalJuryfound Eli Lilly breached the implied covenant of good faith and fair dealing in its rezpegaldesleukin license agreement with Nektar.
●Court petition filed:NextCure asked the Delaware Court of Chancery on September 14, 2026 to validate its July 2025 reverse stock split.
●Priority Review Granted::The FDA accepted with Priority Review Pharming's supplemental New Drug Application to extend Joenja to APDS patients aged 4 and older weighing between 13 and 27 kilograms.
●China exit:Fresenius Medical Care is discontinuing its 4008A hemodialysis system and exiting the peritoneal dialysisBusinessin China.
●Net Income:Enlivex recordedNet Incomeof $1.949 billion for the six months ended June 30, 2026, versus a $5.3 million loss a year earlier.
●Biomarker Data::C4 Therapeutics presented new data showing cemsidomide activated T cells and reprogrammed natural killer cells in relapsed or refractory multiple myeloma patients.
●Cannabis exit:Akanda's board decided on September 24, 2026 to stop pursuing cannabis cultivation or future cannabis-related businesses.
CVS Health bounced sharply on Friday, ending an eight-session slide, as healthcare stocks joined technology and industrials at the head of the market.
Amgen (NASDAQ:AMGN) finished among the Dow's three best performers on Friday, lifted by a strong day for healthcare stocks rather than by any news of its own.
Please wait processing your request...